Movement Disorders (revue) - Exploration (Accueil)

Index « Keywords » - entrée « Peripheral Nervous System Diseases (chemically induced) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Peripheral Nervous System (physiopathology) < Peripheral Nervous System Diseases (chemically induced) < Peripheral Nervous System Diseases (classification)  Facettes :

List of bibliographic references indexed by Peripheral Nervous System Diseases (chemically induced)

Number of relevant bibliographic references: 7.
Ident.Authors (with country if any)Title
000890 (2013) Roberto Ceravolo [Italie] ; Giovanni Cossu ; Monica Bandettini Di Poggio ; Lucio Santoro ; Paolo Barone ; Maurizio Zibetti ; Daniela Frosini ; Valentina Nicoletti ; Fiore Manganelli ; Rosa Iodice ; Marina Picillo ; Aristide Merola ; Leonardo Lopiano ; Alessandra Paribello ; Davide Manca ; Maurizio Melis ; Roberta Marchese ; Paolo Borelli ; Alessandra Mereu ; Paolo Contu ; Giovanni Abbruzzese ; Ubaldo BonuccelliNeuropathy and levodopa in Parkinson's disease: evidence from a multicenter study.
001641 (2011) Tiago Teodoro [Portugal] ; Daniela Pires [Portugal] ; Mário M. Rosa [Portugal] ; Miguel Coelho [Portugal] ; Cristina Sampaio [Portugal] ; Joaquim J. Ferreira [Portugal]Has “levodopa‐induced neuropathy” been reported in Parkinson's disease clinical trials?
001733 (2011) Andrea Cortese [Italie] ; Roberta Zangaglia [Italie] ; Alessandro Lozza [Italie] ; Giovanni Piccolo [Italie] ; Claudio Pacchetti [Italie]Copper deficiency in Wilson's disease: Peripheral neuropathy and myelodysplastic syndrome complicating zinc treatment
001734 (2011) Francisco Pereira Da Silva-Júnior [Brésil] ; Leandro Tavares Lucato [Brésil] ; Alexandre Aluizio Costa Machado [Brésil] ; Egberto Reis Barbosa [Brésil]Copper deficiency in Wilson's disease: An avoidable complication of treatment
001A49 (2010) Cory Toth [Canada] ; Oksana Suchowersky [Canada] ; Douglas Zochodne [Canada]Reply: Neuropathy as a potential complication of levodopa use in Parkinson's disease: A pharmacological and pharmacovigilance point of view
002065 (2009) Davide Manca [Italie] ; Giovanni Cossu [Italie] ; Daniela Murgia [Italie] ; Andrea Molari [Italie] ; Paola Ferrigno [Italie] ; Emanuele Marcia [Italie] ; Maurizio Melis [Italie]Reversible encephalopathy and axonal neuropathy in Parkinson's disease during duodopa therapy
006622 (1987) Klawans [États-Unis]Dystonia and tremor following exposure to 2,3,7,8‐tetrachlorodibenzo‐p‐dioxin

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Peripheral Nervous System Diseases (chemically induced)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Peripheral Nervous System Diseases (chemically induced)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Peripheral Nervous System Diseases (chemically induced)
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024